578 related articles for article (PubMed ID: 10792371)
1. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
[TBL] [Abstract][Full Text] [Related]
2. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
Piechota-Polanczyk A; Włodarczyk M; Sobolewska-Włodarczyk A; Jonakowski M; Pilarczyk A; Stec-Michalska K; Wiśniewska-Jarosińska M; Fichna J
Dig Dis Sci; 2017 Jun; 62(6):1511-1517. PubMed ID: 28391416
[TBL] [Abstract][Full Text] [Related]
3. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
[TBL] [Abstract][Full Text] [Related]
4. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
[TBL] [Abstract][Full Text] [Related]
5. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Kenney JS; Baumann R; Poindron P; Duclos B
Gut; 1996 Nov; 39(5):684-9. PubMed ID: 9026483
[TBL] [Abstract][Full Text] [Related]
6. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis.
Kankuri E; Hämäläinen M; Hukkanen M; Salmenperä P; Kivilaakso E; Vapaatalo H; Moilanen E
Scand J Gastroenterol; 2003 Feb; 38(2):186-92. PubMed ID: 12678336
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B
Gut; 1997 Apr; 40(4):475-80. PubMed ID: 9176074
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.
Biancheri P; Brezski RJ; Di Sabatino A; Greenplate AR; Soring KL; Corazza GR; Kok KB; Rovedatti L; Vossenkämper A; Ahmad N; Snoek SA; Vermeire S; Rutgeerts P; Jordan RE; MacDonald TT
Gastroenterology; 2015 Nov; 149(6):1564-1574.e3. PubMed ID: 26170138
[TBL] [Abstract][Full Text] [Related]
9. Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease.
Woywodt A; Ludwig D; Neustock P; Kruse A; Schwarting K; Jantschek G; Kirchner H; Stange EF
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):267-76. PubMed ID: 10333199
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease.
Gibson P; Rosella O
Gut; 1995 Oct; 37(4):536-43. PubMed ID: 7489942
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
12. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
[TBL] [Abstract][Full Text] [Related]
14. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
von Lampe B; Barthel B; Coupland SE; Riecken EO; Rosewicz S
Gut; 2000 Jul; 47(1):63-73. PubMed ID: 10861266
[TBL] [Abstract][Full Text] [Related]
16. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies.
Dionne S; Hiscott J; D'Agata I; Duhaime A; Seidman EG
Dig Dis Sci; 1997 Jul; 42(7):1557-66. PubMed ID: 9246063
[TBL] [Abstract][Full Text] [Related]
17. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
19. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.
Wang YD; Yan PY
World J Gastroenterol; 2006 Oct; 12(37):6050-3. PubMed ID: 17009408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]